NEW YORK (AP ... Article continues below this ad The drugmaker posted revenue of $17.76 billion in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $17.5 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback